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Abstract
Background: As engineered biological systems become more complex, it is increasingly common to express
multiple operons from different plasmids and inducible expression systems within a single host cell. Optimizing
such systems often requires screening combinations of origins of replication, expression systems, and antibiotic
markers. This procedure is hampered by a lack of quantitative data on how these components behave when more
than one origin of replication or expression system are used simultaneously. Additionally, this process can be time
consuming as it often requires the creation of new vectors or cloning into existing but disparate vectors.
Results: Here, we report the development and characterization of a library of expression vectors compatible with
the BglBrick standard (BBF RFC 21). We have designed and constructed 96 BglBrick-compatible plasmids with a
combination of replication origins, antibiotic resistance genes, and inducible promoters. These plasmids were
characterized over a range of inducer concentrations, in the presence of non-cognate inducer molecules, and with
several growth media, and their characteristics were documented in a standard format datasheet. A three plasmid
system was used to investigate the impact of multiple origins of replication on plasmid copy number.
Conclusions: The standardized collection of vectors presented here allows the user to rapidly construct and test
the expression of genes with various combinations of promoter strength, inducible expression system, copy
number, and antibiotic resistance. The quantitative datasheets created for these vectors will increase the
predictability of gene expression, especially when multiple plasmids and inducers are utilized.
Background
Metabolic engineering, the redirection of metabolic
pathways using genetic manipulation, plays an important
role in a wide range of biological research including
drug production, bioremediation, and biofuel production
[1-5]. Metabolic pathways that lead to important drugs
or chemicals are often multi-step processes involving
many enzymes. In addition, controlling and coordinating
the activity of each enzyme to achieve the optimal pro-
duction of the target product is extremely complicated
[6-9]. To construct an entire metabolic pathway in a
heterologous host, the genes encoding the pathway
enzymes often have to be constructed on multiple plas-
mids. Furthermore, the expression of each enzyme
needs to be tuned to balance it with that of the other
enzymes in the pathway and to reduce the metabolic
burden on the host cell [6,9-11]. Recently, several
advanced cloning methods using homologous recombi-
nation, such as Sequence and Ligation-Independent
Cloning (SLIC), Gibson DNA assembly, and ‘DNA
assembler’, have been reported and applied to construct
large plasmids or chromosomes that encode metabolic
pathways [12-14]. However, these methods require non-
standardized homologous complementary sequences for
each gene part and are limited in terms of automation
and the number of DNA fragments to be assembled to
build a combinatorial library for pathway optimization.
Synthetic biology is an emerging field with large
potential in engineering biological systems and has been
a powerful tool for metabolic engineering [2,15-17]. Syn-
thetic biology focuses on the design and construction of
biological parts that can be understood, designed, and
tuned to meet specific performance criteria. These parts
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are then assembled into larger integrated systems to
solve specific problems [15,18].
The standardization of biological parts and their
assembly is one of the core ideas behind synthetic biol-
ogy. To achieve this with parts (e.g., ribosome binding
sites, promoters, DNA binding proteins, etc.) researchers
at MIT established the BioBricks™ standard (so called
BBF RFC 10) [19]. BglBrick standard (so called BBF
RFC 21) is a recently proposed standard that uses 4
unique restriction enzyme sites (EcoRI, BglII, and
BamHI, XhoI) different from BioBricks™ standard [20]
(Figure 1). The standardized assembly approach such as
BioBricks or BglBricks does not require PCR amplifica-
tion step and consequently, the post-assembly sequence
verification step is optional. It is especially useful when
constructing metabolic pathways that are encoded by
many genes and need to be assembled in various combi-
nations to search for improved phenotypes.
The construction of vectors using BioBricks™ stan-
dard biological parts has been reported recently [21].
These vectors were constructed by various combinations
of BioBricks™ compatible parts and BioBrick™ base
vector (BBa_I51020) using BioBricks™ gene assembly
protocol. In metabolic engineering research, several sets
of such vectors–with different combinations of replica-
tion origin, promoter, and antibiotic resistance mar-
kers–would be a very useful tool to test and optimize
the production of specific target molecules. In this
report, we describe a large set of vectors that are com-
patible with BglBrick parts. These vectors contain
commonly used replication origins, inducible gene
expression systems, and antibiotic resistance markers.
After constructing these expression vectors, we tested
and quantified their ability to express fluorescent pro-
teins that were spliced into them. The resulting infor-
mation is presented in datasheets that will allow
engineers to design metabolic pathways with greater
control.
Results
Construction of BglBrick vectors
Construction of intermediate BglBrick vectors
To construct a set of vectors compatible with BglBrick
sites, we have chosen four different replication origins
belonging to different incompatibility groups and having
different copy numbers. The ColE1 replication origin
has been used to make a relatively high copy version of
the vector, the p15A origin for a medium copy version,
the SC101 origin for a low copy version, and the
pBBR1, a broad host range origin, for a second medium
copy version. (Figure 2) We have introduced a few point
mutations into the Rep gene of pBBR1 origin to engi-
neer a copy number about 6-fold higher than the non-
mutated origin as previously reported [22].
Since some of the vector components have BglBrick
restriction sites (EcoRI, BglII, BamHI, XhoI) in their ori-
ginal sequence, we had to mutate them to remove these
sites. Site-directed mutagenesis was used to make a sin-
gle nucleotide substitution to eliminate the restriction
sites from these components in the intermediate
Figure 1 Schematic diagram of the BglBrick part assembly. Four unique restriction sites (EcoRI, BglII, BamHI, and XhoI) are used for the
BglBrick standard assembly. KAN is the kanamycin resistance marker.
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plasmids, and when the mutation site occurred within
an open reading frame, E. coli codon usage was taken
into consideration.
Construction of expression module
The promoter system modules consisted of one of 8 dif-
ferent promoters and corresponding repressors. We
have chosen the promoters that have been frequently
used for protein production and metabolic pathway
engineering. For IPTG-inducible promoters, the Trc and
T7 promoters were chosen as strong promoters and
PlacUV5 as medium strength promoter [23]. Each con-
struct carried lacIq to repress expression from these pro-
moters. PLlacO-1 was also added to the IPTG-inducible
promoter list because of its tight regulation with med-
ium- to high-level expression. Several promoters
induced by chemicals other than IPTG were included in
the promoter list: tetracycline-regulated gene expression
system (Ptet and tetR) [24], the recently developed pro-
pionate-regulated gene expression system (PprpB and
prpR) [25,26], and the arabinose-inducible promoter
Figure 2 Plasmid design and nomenclature of BglBrick plasmids (pBb). (A) Plasmid design of pBb vectors. The plasmid is composed of
three modules: antibiotic resistance gene module, replication origin module, and expression module, which includes the repressor, promoter,
gene of interest (rfp or gfp), and terminator. BglBrick sites are in red boxes. (B) Nomenclature of the pBb vector system. The identity of the vector
is described by three letters containing the information of replication origin, promoter, and antibiotic resistance marker as indicated. The prefix
pBb is used for BglBrick plasmids and the protein gene name in the plasmid is included at the end of the vector description.
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system (PBAD and araC) [27]. The list of promoters is
described in Figure 2(B).
Construction of promoter-rfp-terminator module and final
pBb vector assembly
The modules with promoter system and rfp-terminator
were constructed by SOE-PCR. Each vector contains a
5’-UTR and rfp between the BglII and BamHI sites. This
operon was used to characterize expression from the
vectors and can be used to screen against background
vector when cloning other operons into these vectors.
We have designed a systematic naming rule for these
BglBrick vectors that describes types of replication ori-
gin, promoter, antibiotic resistance, and the gene
included as a BglBrick part. This naming scheme is
described in Figure 2(B).
Data sheet experiments
Performing a quantitative characterization of a biological
parts and then summarizing the properties of the parts
on datasheets has been previously described [18]. A
similar type of datasheet should be useful when the
BglBrick vectors are used to produce a single target pro-
tein or all of the enzymes in an entire metabolic path-
way. A summary of gene expression and cell growth
behavior of a specific plasmid in a specific host strain
can be a valuable resource for determining which ori-
gin-promoter-resistance combination would be most
useful for a particular metabolic engineering project.
We prepared 32 datasheets for the vectors that have
different replication origins and promoters. The PDF
files of datasheets are currently available from the JBEI
Public Registry (https://public-registry.jbei.org) and also
as Additional file 1 (an example of the datasheet is
shown in Figure 3). We used only ampicillin-resistant
BglBrick vectors for the datasheet experiments based on
the assumption that antibiotic resistance does not signif-
icantly affect the expression property and copy number
of BglBrick vectors [28]. In the datasheet, we included a
plasmid map and the experimentally-determined copy
number, expression, and growth properties of E. coli
strains harboring a specific BglBrick plasmid under var-
ious conditions (several inducer concentrations, different
types of culture medium, high glucose concentration for
catabolite repression, and the presence of other inducers
that might alter expression from the target promoter)
[29].
Data sheet experiment: inducer dose response
The level of protein production usually depends on
inducer concentration, and this expression profile is
important information when using the BglBrick vectors
for metabolic engineering, which frequently requires
tight control of the metabolic pathway. RFP expression
(or GFP expression for pBbB vectors) at different indu-
cer doses was tested in E. coli BLR(DE3) grown in LB
medium with ampicillin. pBbE5a-RFP in LB-ampicillin
medium induced with 100 μM IPTG was used as a con-
trol for all the measurements (pBbE5a-GFP was used as
a control for pBbB vectors). The concentration range
for each inducer was determined based on simple scan-
ning over a wide range of inducer concentrations with
the high copy (ColE1 origin) BglBrick plasmid. For
IPTG-inducible systems, the production of fluorescent
protein was monitored at up to 500 μM IPTG, and for
plasmids with the Tet-inducible promoter, propionate-
inducible promoter, and arabinose-inducible promoter,
the production of fluorescent protein was monitored at
up to 200 nM of aTc, 100 mM of propionate, and 20
mM of arabinose, respectively. A plot containing average
and specific fluorescence (fluorescence from RFP or
GFP/OD600) as a function of time was created for each
inducer concentration, and the data were also presented
as a bar graph at different inducer concentration at a
single time point (18 hrs after induction) (Figure 3).
Most BglBrick plasmids showed clear dose-dependent
expression (Figure 3 and Additional file 1 for more
datasheets).
Data sheet experiments: strain and medium dependence
Strain and medium dependence of BglBrick plasmids are
important properties to consider when selecting the vec-
tors and the medium for metabolic pathway expression,
and they were examined in two frequently used E. coli
strains (BLR(DE3) and DH1). Three different growth
media (minimal medium (M9) and rich media (LB and
TB)) were used to test fluorescence protein production
from these two strains. Most BglBrick vectors, except
those with propionate inducible promoters, showed
almost no strain dependence with the strongest expres-
sion in TB medium and the weakest expression in mini-
mal medium in general, as expected. Plasmids
containing the T7 promoter were not tested in DH1
since DH1 lacks T7 RNA polymerase.
The propionate-inducible promoters showed unusual
behavior in different strains and in different media. For
example, pBb{A, E, or S}3a-rfp (or pBbB3a-gfp) plasmids
in BLR(DE3) showed normal expression behavior in LB
medium but almost no expression in TB medium.
Recently, it has been found that in addition to the native
inducer, propionate, this promoter system is also regu-
lated by carbon catabolite repression (CCR) mediated by
several sugars like glucose, arabinose, mannose, xylose,
galactose and glycerol [24]. This CCR mediated regula-
tion could be the reason for the lack of expression from
these plasmids in BLR(DE3) in TB medium as the med-
ium contains 0.2% glycerol. Interestingly, when the same
vectors were tested in DH1, fluorescent protein was pro-
duced both in LB and TB media. However, expression
was very leaky in these media; protein was produced
regardless of the concentration of propionate. These
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results indicate that the propionate inducible expression
systems are host-dependent.
Data sheet experiments: catabolite repression and inducer
crosstalk
Carbon catabolite repression (CCR) in E. coli is a regula-
tory mechanism to ensure sequential utilization of car-
bohydrates [30]. In metabolic engineering, glucose is
frequently supplemented at high concentration in the
medium as the primary or only carbon source, and it is
important to know whether the transcriptional machin-
ery of the pathway works normally in the presence of
high concentrations of glucose. The effect of glucose for
each BglBrick plasmid (in BLR(DE3)) was tested in the
three different media containing 1% glucose. As control
Figure 3 Datasheet for the pBbE5 vector. The datasheet includes a general description of BglBrick vector and a summary of its expression
properties.
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experiments, the media without additional glucose were
also used for the expression of fluorescent protein with
or without inducer. All the vectors with a version of the
lac promoter were repressed by the addition of 1% glu-
cose. Leaky expression from these plasmids in TB med-
ium decreased dramatically in presence of additional
glucose. Vectors with the tetracyclin-inducible promoter
were less susceptible to catabolite repression, showing
only about 20% less protein production when expressed
in LB with 1% glucose compared to the production in
LB without additional glucose. Vectors with the arabi-
nose-inducible promoter were also repressed by glucose,
and more repression was observed in LB with 1% glu-
cose than in the other media tested. Vectors with pro-
pionate-inducible promoters (promoter numbers 3 and
4) were very strongly repressed by the presence of 1%
glucose in both LB and TB media. But interestingly,
they showed less repression in minimal medium when
1% glucose was added.
To optimize or balance the expression of proteins in a
metabolic pathway, the pathway genes are frequently
placed under control of different promoters, each of
which may use a unique inducer to regulate transcrip-
tion. Unfortunately, there can be substantial crosstalk
among some inducible systems that makes independent
regulation difficult [29]. The potential crosstalk between
various inducible promoters in BglBrick plasmids was
tested at the inducer concentrations that achieved the
highest protein expression in LB medium with BLR
(DE3). Some IPTG-inducible systems (Ptrc and PlacUV5)
did not show any crosstalk in the presence of 20 mM
arabinose, but PLlacO1 and PT7 showed about 15-20%
decrease in fluorescent protein production when 20 mM
arabinose was added to the medium. Also, Ptrc and PT7
did not show any crosstalk toward aTc and propionate,
but PlacUV5 and PLlacO1 showed about 30-40% increase
in protein production in the presence of 400 nM aTc or
20 mM propionate. Ptet performance decreased about
10-15% when 20 mM arabinose or 20 mM propionate
was added, but was not affected by the presence of 100
μM IPTG. The propionate-inducible expression system
did not function well in the presence of 20 mM arabi-
nose: expression from Ppro in the presence of arabinose
was 20-30% of that in the absence of arabinose. BglBrick
plasmids with PBAD showed the most independent beha-
vior in the presence of other inducers.
The mechanism by which arabinose represses the
non-PBAD promoters is not clear, but one potential
explanation could be the decreased level of cAMP-CRP
in the presence of arabinose. As endogenous arabinose
promoters are turned on by the addition of arabinose,
the cAMP-CRP concentration may decrease since the
cAMP-CRP also binds to the araB promoter and the
cell does not have enough cAMP-CRP to bind to the lac
promoter or propionate-inducible promoter. This still
cannot explain the repression of Ptet by high level of
arabinose, and more studies on the crosstalk of these
promoters and inducers needs to be conducted.
Data sheet experiment: Plasmid copy number determination
Real-time quantitative PCR was used to determine the
copy numbers of plasmids [22,31-35] with the available
origins of replication in our system. Copy numbers were
determined for plasmids transformed into both E. coli
BLR and DH1. The single copy nptII gene harbored on
the plasmid was used as the target to measure plasmid
copy number, with the multi-copy 16S rDNA gene har-
bored on host chromosome [36] having been used for
normalization purposes [22,34,35]. Here, plasmid copy is
defined as the number of copies of plasmid present per
chromosomal equivalent in E. coli [37], and absolute
plasmid copy numbers were obtained by using BLR and
DH1 transgenic strains containing a single nptII (inte-
grated into the intA site on the chromosome of DH1
and into the tyrR site on the chromosome of BLR) as
the reference sample. The plasmid copy numbers
obtained for strains with a single plasmid of a particular
replication origin are comparable to those found in the
literature (Figure 4(A)) [38,39]. While the pSC101** ori-
gin is a derivative of pMPP6 [40], we have found com-
parable copy numbers for plasmids with wild-type
pSC101, pMPP6, or pSC101** origins of replication
(data not shown). It is also worth noting that similar
copy numbers were obtained for a given plasmid trans-
formed into either E. coli BLR or DH1 (Figure 4(A)),
suggesting that these two strains do not differentially
impact the regulation of plasmid copy number for the
replication origins employed here.
From the results of strain and media dependence, cat-
abolite repression, and inducer crosstalk experiments,
the propionate inducible vectors may not be a good
choice to be used in metabolic engineering for chemical
or biofuel production, both of which frequently require
high levels of carbon source and multiple plasmids
under different expression machinery to optimize pro-
duction. The propionate system has been reported to be
useful for toxic protein production [26], but additional
studies on its expression and regulation would be infor-
mative for its use in more complex systems.
Application of BglBrick plasmids
Expression of different fluorescent proteins from multiple
plasmids in the same cell
The next step was to test the application of multiple
BglBrick plasmids for orthogonal protein expression,
and we chose BlgBrick plasmids with PBAD, PlacUV5 and
Ptet promoters for these studies. To examine the expres-
sion control using these vectors, we tested the orthogo-
nal protein production of the BglBrick vector system
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using three different fluorescent proteins. Each E. coli
BLR(DE3) cell carried three BglBrick vectors, each with
a unique replication origin, antibiotic resistance, and
promoter: pBbA8a-CFP, pBbE5c-YFP and pBbS2k-RFP.
These vectors contained cfp, yfp, and rfp under the con-
trol of PBAD, PlacUV5, and Ptet, respectively. Fluorescence
excitation and emission wavelengths were carefully cho-
sen so that there would be little overlap of fluorescence
excitation and emission spectra between CFP, YFP, and
RFP fluorescence detection.
When CFP fluorescence was measured, a clear depen-
dence on arabinose concentration from 0 (low) to 5
mM (medium) to 20 mM (high) was observed (Figure
5). At the same arabinose concentration, variation in
IPTG and aTc concentration had no effect on CFP
fluorescence, indicating that PBAD in the BglBrick vector
system was only inducible by arabinose, but not by
IPTG and aTc, at least at the tested concentrations.
Similar results were obtained for RFP fluorescence. At
four tested aTc concentrations, rfp exhibited low (0
aTc), medium-low (12.5 nM aTc), medium-high (25 nM
aTc), and high (40 nM aTc) expression. Both IPTG and
arabinose had no significant effect on RFP fluorescence,
indicating that Ptet is only responsive to aTc.
For PlacUV5, YFP fluorescence increased with IPTG
concentration, confirming that PlacUV5 is responsive to
IPTG. However, we also observed that increasing the
arabinose concentration slightly increased the YFP fluor-
escence. This was not caused by the CFP’s contribution
to the YFP fluorescence signal, because otherwise stron-
ger arabinose dependence would be expected in the
absence of IPTG since low YFP expression would make
the effect most apparent. On the other hand, increasing
aTc concentration slightly decreased YFP fluorescence.
This is also not due to the RFP’s contribution to the
YFP fluorescence, because the opposite effect - increas-
ing in YFP fluorescence as aTc increases - would be
expected. Previously, crosstalk between the IPTG-indu-
cible Plac and the arabinose-inducible PBAD was observed
but the molecular mechanism remains unclear [29]. One
possible reason for this crosstalk may be the non-speci-
fic binding of AraC or TetR to PlacUV5. Regardless of the
cause, the most apparent dependence of YFP fluores-
cence is on IPTG concentration. Overall, we demon-
strated that three promoters from the BglBrick vectors
can be orthogonally induced.
Copy number of plasmid in multiple plasmid strain
In order to assess the impact of metabolic burden on
plasmid copy number, we determined the copy number
of individual plasmids in a cell harboring all three plas-
mids. Here, E. coli BLR and DH1 were co-transformed
with pSC101**-, p15A-, and ColE1-containing plasmids.
Each plasmid harbored a different selection marker
(resistance to ampicillin, chloramphenicol, or kanamy-
cin), and cultures were grown in media supplemented
with all three antibiotics. Using real-time quantitative
PCR, absolute copy number was determined for the
plasmid harboring the kanamycin selection marker
Figure 4 BglBrick plasmid copy numbers in DH1 and BLR(DE3).
The blue bars are for DH1 strains, and the purple bars are for BLR
(DE3) strains. The dark colored bars are for the single-plasmid strain,
and the light colored bars are for the three-plasmid strain
containing pBbA8a-CFP, pBbE5c-YFP and pBbS2k-RFP. Plasmids with
the pBBR1 origin were not tested in the three-plasmid strain. (A)
Plasmid copy number for single plasmid strain (B) DH1 plasmid
copy number comparison for single and three plasmid strain (C)
BLR(DE3) plasmid copy number comparison for single and three
plasmid strain.
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nptII. The results obtained (Figure 4(B), (C)) indicate
that plasmids containing the p15A and ColE1 origins
had a higher copy number in cells harboring all three
plasmids than in cells harboring a single plasmid. For
pSC101**, on the other hand, the copy number was
unchanged from that observed under single plasmid
conditions. Our results are consistent with those found
in literature [28,41] and may be explained by differences
in the replication control mechanism of the origins. As
a broad generalization, plasmid replication control is
either relaxed or stringent, with plasmid replication
being uncoupled from host chromosomal DNA synth-
esis in the former case [42]. ColE1 and related plasmids
(which includes p15A) replicate under relaxed control
while pSC101 is stringent [43]. Consistent with our
results (Figure 4), variation in pSC101 copy number is
thus not to be expected under stress conditions because
plasmid replication is tightly coupled to the bacterial
cell cycle.
Conclusion and Discussion
Synthetic biology provides a powerful tool that can be
applied to a variety of goals: engineering metabolic
pathways, overproducing a specific protein, examining
fundamental biology. In this report, we describe expres-
sion vectors that would be useful to researchers using
BglBrick standard to express single genes or entire
metabolic pathways. We assembled a library of expres-
sion vectors to be compatible with a recently-developed
BglBrick standard, and as a result, any DNA sequences
with BglBrick standard format can be cloned into these
vectors. In addition, we designed the vectors to allow
for precise control of the expression of multiple genes,
whether that be to construct a metabolic pathway or for
any other multi-gene expression project. The datasheets
for these BglBrick vectors provide information about
their expression properties under various conditions (e.
g., medium, strain, and with different inducers). These
datasheets will serve as an initial point of reference
when designing and optimizing complex gene expres-
sion systems.
In the report, we demonstrated the compatible and
controllable aspects of the vectors with fluorescent
proteins as a model system only. In addition, we have
used these vectors to construct complex metabolic
pathways, such as the isoprenoid biosynthetic pathway
Figure 5 Expression of three different proteins from a single strain at various inducer concentrations. pBbA8a-cfp, pBbE5c-yfp and
pBbS2k-rfp were transformed in E. coli BLR(DE3) and the fluorescent proteins were expressed under various inducer concentration combinations.
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[44], and to express a library of membrane transporter
proteins [45]. These works involved the transformation
of host cells with either multiple plasmids or single
plasmid containing different genes expressed at various
levels.
All the BglBrick vectors and their datasheets have
been deposited in Joint BioEnergy Institute Public Regis-
try (https://public-registry.jbei.org) and are available for
searching and reviewing the sequences and annotations.
We also made these vector strains and datasheets avail-
able through institutional strain distributor and a non-
profit strain distributing organization, such as Addgene
(http://www.addgene.org) with an appropriate material
transferring process.
To expand the use of these vectors for further applica-
tion, various additional biological parts can be designed
with the BglBrick format. For example, new parts com-
posed of a combination of various terminators and pro-
moters have been designed to make multiple operon
variants of BglBrick plasmids (data not shown). These
parts can be appended or prepended either to original
BglBrick vectors or to BglBrick plasmids already con-
taining pathway genes to allow co-expression of differ-
ent pathways or genes from the same plasmid. In
addition, variants of the BglBrick plasmids described
here that do not include any specific promoter-repressor
components have been prepared (Additional file 2).
These variants would expand the use of BglBrick vectors
for application with various natural or synthetic
promoters.
Finally, the concept of standardized biological parts
allows automated assembly of recombinant DNA and
will likely prove to be a powerful tool in engineering
biological systems. Recently, the automated DNA assem-
bly using BglBrick standard and 2 antibiotic (2ab)
assembly strategy has been reported [46]. In this report,
an automated assembly protocol was introduced for
high throughput parallel assembly of BglBrick part
DNAs. The BglBrick vectors we report here are compa-
tible to this automation strategy and can also be used
for assembling various combinations of pathway genes
for the screening to optimize any target metabolic
pathway.
Methods
Strains and plasmids
E. coli DH10B was used for cloning. E. coli BLR (DE3)
and DH1 were used for expression studies with BglBrick
vectors. Plasmids and BglBrick parts used in this study
are listed in Table 1. Media were supplemented with
100 μg/mL ampicillin, 35 μg/mL chloramphenicol, or 50
μg/mL kanamycin to select for plasmid maintenance.
All strains were grown at 30°C unless described
otherwise.
Construction of BglBrick vector parts
The template plasmids or parts for the BglBrick vectors
constructed here are listed in Table 1 and the primers
for PCR amplification are listed in Table 2. Each gene
component has been either PCR amplified from a tem-
plate using Phusion™ High-Fidelity DNA polymerase
(New England BioLabs, F-530) or digested from tem-
plate plasmids and incorporated into the BglBrick vector
plasmid by standard restriction digestion/ligation
method.
Replication origins
The p15A origin was obtained from plasmid pZA31-luc,
the ColE1 origin from plasmid pZE12-luc, and the
pSC101* origin from plasmid pZS*24-MCS1 [39]. A
BglII site in the pSC101* origin was eliminated by site-
directed mutagenesis. The oligonucleotides used to
remove the BglII site in the pSC101* origin were
pSC101QC F1 and pSC101QC R1 creating pSC101**.
Each origin of replication and terminator sequence
module was cloned in using the AvrII and SacI sites.
Plasmid pMBIS was used as template for the pBBR1 ori-
gin. The BBR1 region was amplified in two parts, and
primers were designed to make a C to T point mutation
in the overlapping region of the two PCR products to
increase the copy number as reported [22]. Forward
Table 1 Summary of plasmids and parts used for the
construction of BglBrick vector
Plasmid/Part Name Component function Reference
pZA31-luc Cm [44]
T0 of phage lambda
p15A origin
pZE12-luc Amp [44]
ColE1 origin
pZE21-MCS1 Kan [44]
PLlacO-1
pZS*24-MCS1 pSC101* [44]
pZB Tet repressor [29]
Tet promoter
pET-29b(+) T7 promoter Novagen
RBS
lacI
pTrc99A Ptrc Pharmacia
lacIq
pBAD33 PBAD [32]
pPro24 pPro(E) [30]
pPro29b pPro(S) [31]
BBa_E1010 rfp [26]
BBa_B0015 double terminator [27]
pAM45 PlacUV5 [28]
pMBIS pBBR1 origin [6]
pBMOE1 gfp without BamHI site J. Dietrich, unpublished
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primer pBBR1 F1 (5’- gatcaCCTAGGctacagccgatagtctg-
gaacagcgc -3’) and reverse primer pBBR1 mut R1 (5’-
ccggcaccgtgtTggcctacgtggtc -3’) were used to generate
the first product with a 5’-AvrII site, and forward primer
pBBR1 mut F1 (5’- gaccacgtaggccAacacggtgccgg -3’) and
reverse primer pBBR1 R2 (5’- agatcaACTAGT
gcctccggcctgcggcctgcgcgcttcg -3’) were used to generate
the second product with a 3’- SpeI site. These two parts
were then combined in a splice overlap extension-PCR
(SOE-PCR) reaction with primers pBBR1 F1 and pBBR1
R2 to create the product containing the entire pBBR1
origin of replication. The PCR product was digested
with AvrII and SpeI and ligated with existing intermedi-
ate vectors to generate three additional intermediate
vectors containing pBBR1 and each antibiotic resistance
module.
Antibiotic resistance
All antibiotic resistance segments (SacI to AatII) were
digested from the parent plasmids listed in Table 1. The
BglBrick restriction site found in Cm and Km resistance
gene components were removed by site-specific muta-
genesis. The oligonucleotides used to remove the EcoRI
site in the Cm resistance gene were the forward CmQC
F1 (5’-ctttcattgccatacgAaattccggatgagcattc-3’) and
reverse CmQC R1 (5’-gaatgctcatccggaattTcgtatggcaat-
gaaag-3’) (point mutation is capitalized). The oligonu-
cleotides used to remove the BglII site in the Km
Table 2 Primers for BglBrick vector construction
Name Primers for promoter system Description
pSC101QC F1 5’- gaatttacagatacccagatcAcccgggaaaagg-3’ to remove BglII site on pSC101
pSC101QC R1 5’- ccttttcccgggTgatctgggtatctgtaaattc-3’ to remove BglII site on pSC101
pBBR1 F1 5’- gatcaCCTAGGctacagccgatagtctggaacagcgc -3’ for pBBR1 origin with AvrII
pBBR1 mut R1 5’- ccggcaccgtgtTggcctacgtggtc -3’ to increase copy number of pBBR1
pBBR1 mut F1 5’- gaccacgtaggccAacacggtgccgg -3’ to increase copy number of pBBR1
pBBR1 R2 5’- agatcaACTAGTgcctccggcctgcggcctgcgcgcttcg -3’ for pBBR1 origin with SpeI
CmQC F1 5’-ctttcattgccatacgAaattccggatgagcattc-3’ to remove EcoRI site on CmR
CmQC R1 5’-gaatgctcatccggaattTcgtatggcaatgaaag-3’ to remove EcoRI site on CmR
KanQC F1 5’- cctgtctcttgatcagatcAtgatcccctgc-3’ to remove BglII site on KmR
KanQC R1 5’- gcaggggatcaTgatctgatcaagagacagg-3’ to remove BglII site on KmR
RFP F1 5’- aaaAGATCTtttaagaaggagatatacatATGgcgagtagcgaagacgttatc-3’ for rfp with BglII
RFP R1 5’- CTCGAGtttGGATCCttaagcaccggtggagtgacg-3’ for rfp with BamHI and XhoI
Term F1 5’- gtgcttaaGGATCCaaaCTCGAGtaaggatctccaggcatcaaataaaacg-3’ for double terminator with BamHI and XhoI
Term R1 5’- gatcaCCTAGGtataaacgcagaaaggcccacccgaagg -3’ for double terminator with AvrII
pTrc F1 5’- agatcaGACGTCgacaccatcgaatggtgcaaaacc-3’ for Ptrc with AatII
placUV5 R1 5’- tatctccttcttaaaAGATCTtttGAATTCtgaaattgttatccgctcacaattc-3’ for Ptrc, PlacUV5, and PT7 with EcoRI and BglII
pTet F1 5’- agatcaGACGTCttaagacccactttcacatttaagttg-3’ for Ptet with AatII
pTet R1 5’- tatctccttcttaaaAGATCTtttGAATTCttttctctatcactgatagggagtgg-3’ for Ptet with EcoRI and BglII
pProS F1 5’- agatcaGACGTCttaattacccgactggtctttggcac -3’ for Salmonela based PprpB with AatII
pProS R2 5’- gggatatcagcctggaattTgatcatctggcgacc -3’ to remove EcoRI site
pProS F2 5’- ggtcgccagatgatcAaattccaggctgatatccc -3’ to remove EcoRI site
pProS R1 5’- tatctccttcttaaaAGATCTtttGAATTCcatgttagtaaattgttattcaag -3’ for Salmonela based PprpB with EcoRI and BglII
pProE F1 5’- agatcaGACGTCtcagcttttcagccgccgccagaac -3’ for E. coli based PprpB with AatII
pProE R2 5’- gtttcgcgatatcagcctTgagtttgatcacctgg -3’ to remove XhoI site
pProE F2 5’- ccaggtgatcaaactcAaggctgatatcgcgaaac -3’ to remove XhoI site
pProE R1 5’- tatctccttcttaaaAGATCTtttGAATTCttgttatcaacttgttatttgcgttg -3’ for E. coli based PprpB with EcoRI and BglII
lacUV5 F1 5’- agatcaGACGTCggtgcctaatgagtgagctaacttacattaattgc-3’ for PlacUV5 with AatII
PLlacO-1 F1 5’- agatcaGACGTCggtgcctaatgagtgagctaacttacattaattg-3’ for lacI with AatII
PLlacO-1 R2 5’- aatgtcaattgttatccgctcacaattctcgatcctctacgccggacg-3’ for lacI
PLlacO-1 F2 5’- cgtccggcgtagaggatcgagaattgtgagcggataacaattgacatt-3’ for PLlacO-1
PLlacO-1 R1 5’- tatctccttcttaaaAGATCTtttGAATTCggtcagtgcgtcctgctgatgtg-3’ for PLlacO-1 with EcoRI and BglII
pT7 F1 5’- agatcaGACGTCctcactgcccgctttccagtc-3’ for PT7 with AatII
pBAD F1 5’- agatcaGACGTCttatgacaacttgacggctacatcattcac-3’ for PBAD with AatII
pBAD R2 5’- gataaaaagcgtcaggtagAatccgctaatcttatgg-3’ to remove BamHI site
pBAD F2 5’-ccataagattagcggatTctacctgacgctttttatc-3’ to remove BamHI site
pBAD R1 5’-tatctccttcttaaaAGATCTtttGAATTCccaaaaaaacgggtatggagaaacag-3’ for PBAD with EcoRI and BglII
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resistance gene promoter were KanQC F1 (5’-
cctgtctcttgatcagatcAtgatcccctgc-3’) and KanQC R1 (5’-
gcaggggatcaTgatctgatcaagagacagg-3’).
Rfp (or gfp) and terminator
The rfp-terminator (rfp-term) module was constructed
by splice overlap extension-PCR (SOE-PCR [47]. First,
SOE-PCR was performed to generate rfp with BglBrick
restriction sites EcoRI and BglII and RBS (TTTAA-
GAAGGAGATATACAT) on the 5’-end, and with
BglBrick restriction sites BamHI and XhoI and a double
terminator sequence followed by an AatII site on the 3’-
end. Two PCRs were performed to amplify rfp and the
terminator separately, using primers to introduce the
restriction sites, RBS, and overlapping sequence for
SOE-PCR. Forward primer RFP F1 and reverse primer
RFP R1 were used to generate the product containing
EcoRI, BglII, RBS, and rfp. Forward primer Term F1 and
reverse primer Term R1 were used to generate the pro-
duct containing the BamHI, XhoI, the double terminator
sequence and AvrII. The products were then combined
and a second PCR was performed with the RFP F1 and
Term R1. The resulting SOE-PCR product (rfp-term)
was in turn used in additional SOE-PCRs to generate
complete modules containing the 8 different promoter
systems followed by rfp-term.
Promoters and repressors
The primers for each promoter system (containing
repressor and promoter) were engineered to include a
5’AatII site for later cloning steps and an rfp overlapping
sequence on the 3’ end to facilitate the addition of the
rfp-terminator module via SOE-PCR. When the promo-
ter system contained any of the 4 BglBrick restriction
sites, an additional set of primers to remove the restric-
tion site was prepared for SOE-PCR. Primers for each
promoter system are listed in the Table 2.
Final pBb vector assembly
To construct the promoter system with the rfp-termi-
nator module, each of the eight promoter system mod-
ules were combined with rfp-terminator by SOE-PCR
using the F1 primer from each promoter system con-
struction and the reverse primer Term R1. These eight
products were then digested with AatII and AvrII and
individually ligated with the AatII and AvrII digested
fragment from the intermediate plasmid containing
ampR and ColE1. The eleven remaining intermediate
plasmids were then digested with AvrII and AatII to
isolate the antibiotic resistance-replication origin (AR-
ori) modules. In total, each of the twelve AR-ori mod-
ules was ligated with each of the eight AvrII and AatII
digested promoter-rfp-terminator modules to produce
96 unique pBb vectors.
Data sheet experiments
General
Ampicillin-resistant pBb plasmids were transformed into
E. coli BLR(DE3) electrocompetent cells and/or E. coli
DH1 electrocompetent cells and plated on LB-agar with
50 μg/ml Carbenicillin (Cb) for overnight incubation at
37°C. A single colony was picked and used to prepare
the seed culture in LB broth containing 50 μg/ml Cb.
Fresh culture tubes with 3 ml LB broth containing 50
μg/ml Cb were inoculated with 60 μl overnight seed cul-
ture and grown at 37°C, 200 rpm until the OD600
reached about 0.55. All experiments were replicated in
triplicate.
Inducer dose response
The outer wells of a 96-well clear-bottom plate with lid
(Corning no: 3631) were filled with 200 μl sterile water
and the plate was sterilized by using the optimal cross-
link setting on the UV crosslinker (Spectronics, Corp.).
10 × serial dilutions were made of inducers appropriate
for each plasmid being tested and 20 μl was pipetted
into each well so that the final volume of 200 μl would
give 1x inducer concentration. Each plate included 3
control wells containing pBbE5a-RFP (or GFP) in BLR
(DE3) induced with 12.5 μM IPTG. Appropriate
volumes of culture and LB/Cb were added to the 96-
well plate with lid and grown in a Safire (Tecan) micro-
plate reader at 30°C for 20.5 hours. OD600 and RFP
fluorescence were measured every 570 seconds using an
excitation wavelength of 584 nm and an emission wave-
length of 607 nm. For the constructs containing GFP
(pBbB plasmids), an excitation wavelength of 400 nm
and an emission wavelength of 510 nm were used for
fluorescence measurement.
Strain and medium dependence
E. coli BLR(DE3) and DH1 transformed with pBb plas-
mid were streaked on LB-agar with 50 μg/ml Cb and
grown at 37°C overnight. Seed cultures were prepared in
LB broth containing 50 μg/mL Cb inoculated with a sin-
gle colony and grown at 37°C, 200 rpm overnight. Each
experiment with a pBb plasmid-harboring strain was
replicated in triplicate, and each set of experiments
included 6 control tubes containing pBbE5a-RFP in BLR
(DE3) in LB (3 uninduced and 3 induced with 100 μM
IPTG). For the M9 minimal medium (MM) experiment,
three rounds of adaptation were performed in minimal
medium. After adaptation, fresh tubes with 3 mL fresh
MM were inoculated with adapted seed culture to
OD600 approximately 0.15 and grown at 37°C to OD600
of approximately 0.5. One set of tubes were induced at
different inducer concentrations and all cultures were
grown at 30°C, 200 rpm for 66 hours post induction.
Samples were taken at 18 h, 42 h and 66 h post induc-
tion. 25 μL of culture was taken into a 96-well plate and
diluted to 200 μL with fresh medium, and OD600 and
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fluorescence were measured. For LB and TB media
experiments, overnight seed cultures were used directly
for inoculation without adaptation.
Catabolite repression and inducer crosstalk
Seed cultures were prepared as described in strain and
medium dependence experiments. Three different media
(MM, phosphate buffered LB, and phosphate buffered
TB) containing 1% glucose were used for catabolite
repression experiments. Inoculated cultures were grown
at 37°C to OD600 of approximately 0.5, and induced to
achieve maximum expression (100 μM IPTG, 20 mM
arabinose, 400 nM aTc, or 20 mM propionate). Cultures
were grown at 30°C, 200 rpm for 66 hours post induc-
tion, and OD600 and fluorescence was measured at each
sampling. For the inducer crosstalk experiment, LB
broth containing 50 μg/ml Cb was inoculated with seed
cultures containing E. coli BLR(DE3) harboring the
ampicillin-resistant pBb. Cultures were induced at
OD600 of approximately 0.5 with the appropriate indu-
cer, and one of the non-cognate inducers was also
added to the individually induced culture during induc-
tion. Cultures were grown at 30°C, 200 rpm for 18
hours post-induction, and OD600 and fluorescence were
measured using the Tecan.
Bacterial DNA isolation to quantify plasmid copy number
E. coli DH1 and BLR were grown overnight at 30°C, 200
rpm shaking after inoculating 5 mL cultures of LB med-
ium (supplemented with 50 μg/mL kanamycin) with sin-
gle colonies from freshly streaked plates. After sub-
culturing (1:50) into shake flasks containing 50 mL of
LB medium (supplemented with 50 μg/mL kanamycin),
cells were grown at 30°C, 200 rpm shaking until an
OD600 of 0.3-0.4 was reached. At this time, 1 mL of
cells was spun down and the supernatant subsequently
removed. The cell pellets were then frozen. Total DNA
was isolated from these pellets for use at a future date.
The DNA isolation method reported in previous publi-
cations [33,48] was adopted. Bacterial cell pellets were
resuspended in 400 μL of 50 mM Tris/50 mM EDTA,
pH 8, by vortexing. Cell membranes were permeablized
by the addition of 8 μL of 50 mg/mL lysozyme (Sigma)
in 10 mM Tris/1 mM EDTA, pH 8, followed by incuba-
tion at 37°C for 30 min. To complete cell lysis, 4 μL of
10% SDS and 8 μL of 20 mg/mL Proteinase K solution
(Invitrogen) were added to each tube, mixed with a syr-
inge with 21-gauge, 1.5-inch needle, and incubated at
50°C for 30 min. Proteinase K was subsequently heat
inactivated at 75°C for 10 min, and RNA was digested
with the addition of 2 μL of 100 mg/mL RNase A solu-
tion (Qiagen) followed by incubation at 37°C for 30
min. Total DNA extraction then proceeded by adding
425 μL of 25:24:1 phenol:chloroform:isoamyl alcohol,
vortexing vigorously for ~1 min, allowing the tubes to
sit at room temperature for a few minutes, and then
centrifugation for 5 min at 14,000 × g, 4°C. Next, 300
μL of the upper aqueous phase was transferred to a new
tube using a wide-opening pipet tip. DNA extraction
continued by adding 400 μL of chloroform to each tube,
vigorous vortexing for ~1 min, allowing the tubes to sit
at room temperature for a few minutes, and centrifuga-
tion for 5 min at 14,000 × g, 4°C. Next, 200 μL of the
upper aqueous phase was transferred to a new tube
using a wide-opening pipet tip. Following chloroform
extraction, total DNA was ethanol precipitated over-
night, washed with 70% ethanol, and finally resuspended
in 40 μL of nuclease-free water. DNA concentration and
purity were assayed using a Nanodrop spectrophot-
ometer, and integrity examined on 1% agarose gels.
Real-time qPCR quantification of plasmid copy number
Primer sets specific to the neomycin phosphotransferase
II (nptII) gene (forward: GCGTTGGCTACCCGTGA-
TAT, reverse: AGGAAGCGGTCAGCCCAT) [49] and
16S rDNA gene (forward: CCGGATTGGAGTCTG-
CAACT, reverse: GTGGCATTCTGATCCACGATTAC)
[33] were used for real-time qPCR. These primers
amplified a single product of the expected size as con-
firmed by the melting temperatures of the amplicons.
nptII resides in single-copy on the plasmids character-
ized in this study, while 16S rDNA gene resides on mul-
tiple copies on the E. coli chromosome [36] and was
used for normalization [22,33,35]. In order to determine
plasmid copy number (i.e. number of plasmids per
genomic equivalent), E. coli DH1 and BLR transgenic
strains with a single nptII integration (data not shown)
were used for calibration. Total DNA isolated from each
strain was first digested overnight using EcoRI (New
England Biolabs) at 37°C. Real-time qPCR was con-
ducted on a BioRad iCycler with 96-well reaction blocks
in the presence of SYBR Green under the following con-
ditions: 1X iQ SYBR Green Supermix (BioRad), 150 nM
nptII (500 nM 16S) primers in a 25 μL reaction. Real-
time qPCR cycling was 95°C for 3 min, followed by 40
cycles of 30 sec at 95°C, 30 sec at 60°C, and 30 sec at
72°C. Threshold cycles (Ct) were determined with iCy-
cler (BioRad) software for all samples. A standard curve
was prepared for quantification. For this purpose, a
four-fold dilution series of a total of seven dilutions was
prepared from a digested total DNA sample, and each
dilution was subjected to qPCR analysis in at least dupli-
cate with either the nptII- or 16S-specific primers.
Obtained Ct values were used by the iCycler software
package to plot a standard curve that allowed quantifica-
tion of nptII or 16S in the digested total DNA samples
(i.e. unknowns) relative to the DNA sample used to pre-
pare the standard curve.
Expression control in the three-plasmid system
BLR (DE3) cells were transformed with three plasmids:
pBbA8a-CFP, pBbE5c-YFP and pBbS2k-RFP. A single
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colony was used to inoculate LB medium and the over-
night cultures were grown at 37°C in minimal medium
(M9 medium supplied with 75 mM MOPS, 2 mM
MgSO4, 1 mg/L thiamine, 10 nM FeSO4, 0.1 mM CaCl2
and micronutrients) supplemented with 2% glucose.
Cells were induced at OD ~0.6 with combinations of
different amounts of arabinose, IPTG and aTc. In detail,
the arabinose concentrations used were 0, 5 mM, and
20 mM; the IPTG concentrations used were 0, 30 μM,
and 100 μM; and the aTc concentrations used were 0,
12.5 nM, 25 nM, and 40 nM. After induction, cells were
grown at 30°C for 12 hours until cell culture fluores-
cence was measured. Cell culture fluorescence was
recorded on a SpectraMax M2 plate reader (Molecular
Devices) using 96-well Costar plates with each well con-
taining 150 μl of cell culture. For CFP, lex = 433 nm
and lem = 474 nm were used; for YFP, lex = 500 nm
and lem = 530 nm were used; and for RFP, lex = 584
nm and lem = 615 nm were used. Cell density was esti-
mated by measuring the absorbance at 610 nm. Cell cul-
ture fluorescence from each well was normalized by its
cell density. All the data were average from at least two
independent measurements.
List of abbreviation used
BBF: BioBricks Foundation; RFC: request for comments;
RBS: ribosomal binding site; SOE: splice overlap exten-
sion; PCR: polymerase chain reaction; RFP: red fluores-
cent protein; GFP: green fluorescent protein; CFP: cyan
fluorescent protein; YFP: yellow fluorescent protein;
CCR: carbon catabolite repression; aTc: anhydrotetracy-
cline; IPTG: isopropyl-b-D-thiogalactoside; Amp: ampi-
cillin; Km: kanamycin; Cm: chloramphenicol; Cb:
carbenicillin; MM: minimal media; LB: Luria-Bertani;
TB: Terrific broth; OD: optical density; qPCR: quantita-
tive PCR
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Additional file 1: Datasheets for 32 BglBrick vectors. PDF file of the
datasheets for 32 BglBrick vectors.
Additional file 2: Method for the preparation of promoter-less
BglBrick vectors. MS Word file with experimental details for the
preparation of 12 promoter-less BglBrick vectors.
Acknowledgements
We thank Nathan Hillson, Harry Beller (JBEI), and Seth Karten (LBNL) for
helpful comments on the manuscript and Timothy Ham (JBEI) for JBEI
registry works. This work was funded in part by the DOE Joint BioEnergy
Institute (http://www.jbei.org) supported by the U. S. Department of Energy,
Office of Science, Office of Biological and Environmental Research, through
contract DE-AC02-05CH11231 between Lawrence Berkeley National
Laboratory and the U. S. Department of Energy and in part by the Synthetic
Biology Engineering Research Center, which is funded by National Science
Foundation through Award No. 0540879. FZ is funded by NSERC Canada.
Author details
1Joint BioEnergy Institute, 5885 Hollis St., Emeryville, CA 94608, USA. 2Physical
Biosciences Division, Lawrence Berkeley National Laboratory, Berkeley, CA
94720, USA. 3Department of Chemical & Biomolecular Engineering, University
of California, Berkeley, CA 94720, USA. 4Department of Bioengineering,
University of California, Berkeley, CA 94720, USA. 5Department of Electrical
Engineering, University of California, Berkeley, CA 94720, USA. 6Synthetic
Biology Engineering Research Center, University of California, Berkeley, CA,
94720, USA. 7Current Address: Schools of Nano-Bioscience & Chemical
Engineering, Ulsan National Institute of Science and Technology, Ulsan,
Korea.
Authors’ contributions
The BglBrick vectors were designed by TSL, SKL, and JDK. The datasheet was
designed by TSL, RK, and JDK. The vectors were constructed by RK and WJH,
and initial datasheet experiment was performed by RK. Three-plasmid
experiments were performed by FZ and NP, and the copy number
measurement was performed by MH. The manuscript was drafted by TSL,
RK, FZ, MH, WJH, and JDK. All authors read and approved the final
manuscript.
Declaration of competing interests
The authors declare that they have no competing interests.
Received: 21 March 2011 Accepted: 20 September 2011
Published: 20 September 2011
References
1. Khosla C, Keasling JD: Metabolic engineering for drug discovery and
development. Nat Rev Drug Discov 2003, 2(12):1019-25.
2. Lee SK, Chou H, Ham TS, Lee TS, Keasling JD: Metabolic engineering of
microorganisms for biofuels production: from bugs to synthetic biology
to fuels. Curr Opin Biotechnol 2008, 19(6):556-63.
3. Atsumi S, Liao JC: Metabolic engineering for advanced biofuels
production from Escherichia coli. Curr Opin Biotechnol 2008, 19(5):414-9.
4. Raab RM, Tyo K, Stephanopoulos G: Metabolic engineering. Adv Biochem
Eng Biotechnol 2005, 100:1-17.
5. Pieper DH, Reineke W: Engineering bacteria for bioremediation. Curr Opin
Biotechnol 2000, 11(3):262-70.
6. Martin VJ, Pitera DJ, Withers ST, Newman JD, Keasling JD: Engineering a
mevalonate pathway in Escherichia coli for production of terpenoids.
Nat Biotechnol 2003, 21(7):796-802.
7. Pitera DJ, Paddon CJ, Newman JD, Keasling JD: Balancing a heterologous
mevalonate pathway for improved isoprenoid production in Escherichia
coli. Metab Eng 2007, 9(2):193-207.
8. Alper H, Fischer C, Nevoigt E, Stephanopoulos G: Tuning genetic control
through promoter engineering. Proc Natl Acad Sci USA 2005,
102(36):12678-83.
9. Ajikumar PK, Xiao WH, Tyo KE, Wang Y, Simeon F, Leonard E, Mucha O,
Phon TH, Pfeifer B, Stephanopoulos G: Isoprenoid pathway optimization
for Taxol precursor overproduction in Escherichia coli. Science 2010,
330(6000):70-4.
10. Dejong JM, Liu Y, Bollon AP, Long RM, Jennewein S, Williams D, Croteau RB:
Genetic engineering of taxol biosynthetic genes in Saccharomyces
cerevisiae. Biotechnol Bioeng 2006, 93(2):212-24.
11. Yan Y, Kohli A, Koffas MA: Biosynthesis of natural flavanones in
Saccharomyces cerevisiae. Appl Environ Microbiol 2005, 71(9):5610-3.
12. Li MZ, Elledge SJ: Harnessing homologous recombination in vitro to
generate recombinant DNA via SLIC. Nat Methods 2007, 4(3):251-6.
13. Shao Z, Zhao H, Zhao H: DNA assembler, an in vivo genetic method for
rapid construction of biochemical pathways. Nucleic Acids Res 2009, 37(2):
e16.
14. Gibson DG, Young L, Chuang RY, Venter JC, Hutchison CA, Smith HO:
Enzymatic assembly of DNA molecules up to several hundred kilobases.
Nat Methods 2009, 6(5):343-5.
15. Keasling JD: Synthetic biology for synthetic chemistry. ACS Chem Biol
2008, 3(1):64-76.
16. Lee SY, Kim HU, Park JH, Park JM, Kim TY: Metabolic engineering of
microorganisms: general strategies and drug production. Drug Discov
Today 2009, 14(12):78-88.
Lee et al. Journal of Biological Engineering 2011, 5:12
http://www.jbioleng.org/content/5/1/12
Page 13 of 14
17. Martin CH, Nielsen DR, Solomon KV, Prather KL: Synthetic metabolism:
engineering biology at the protein and pathway scales. Chem Biol 2009,
16(3):277-86.
18. Canton B, Labno A, Endy D: Refinement and standardization of synthetic
biological parts and devices. Nat Biotechnol 2008, 26(7):787-93.
19. Knight TFJ: Idempotent Vector Design for Standard Assembly of
Biobricks. DSpace@MIT 2003 [http://hdl.handle.net/1721.1/21168].
20. Anderson JC, Dueber JE, Leguia M, Wu GC, Goler JA, Arkin AP, Keasling JD:
BglBricks: A flexible standard for biological part assembly. Journal of
Biological Engineering 2010, 4(1):1-12.
21. Shetty RP, Endy D, Knight TF Jr: Engineering BioBrick vectors from
BioBrick parts. J Biol Eng 2008, 2:5.
22. Tao L, Jackson RE, Cheng Q: Directed evolution of copy number of a
broad host range plasmid for metabolic engineering. Metab Eng 2005,
7(1):10-7.
23. Anthony JR, Anthony LC, Nowroozi F, Kwon G, Newman JD, Keasling JD:
Optimization of the mevalonate-based isoprenoid biosynthetic pathway
in Escherichia coli for production of the anti-malarial drug precursor
amorpha-4,11-diene. Metab Eng 2009, 11(1):13-9.
24. Lee SK, Newman JD, Keasling JD: Catabolite repression of the propionate
catabolic genes in Escherichia coli and Salmonella enterica: evidence for
involvement of the cyclic AMP receptor protein. J Bacteriol 2005,
187(8):2793-800.
25. Lee SK, Keasling JD: A propionate-inducible expression system for enteric
bacteria. Appl Environ Microbiol 2005, 71(11):6856-62.
26. Lee SK, Keasling JD: Heterologous protein production in Escherichia coli
using the propionate-inducible pPro system by conventional and auto-
induction methods. Protein Expr Purif 2008, 61(2):197-203.
27. Guzman LM, Belin D, Carson MJ, Beckwith J: Tight regulation, modulation,
and high-level expression by vectors containing the arabinose PBAD
promoter. J Bacteriol 1995, 177(14):4121-30.
28. Hajimorad M, Gray PR, Keasling JD: A framework and model system to
investigate linear system behavior in Escherichia coli. J Biol Eng 2011, 5:3.
29. Lee SK, Chou HH, Pfleger BF, Newman JD, Yoshikuni Y, Keasling JD:
Directed evolution of AraC for improved compatibility of arabinose- and
lactose-inducible promoters. Appl Environ Microbiol 2007, 73(18):5711-5.
30. Gorke B, Stulke J: Carbon catabolite repression in bacteria: many ways to
make the most out of nutrients. Nat Rev Microbiol 2008, 6(8):613-24.
31. Skulj M, Okrslar V, Jalen S, Jevsevar S, Slanc P, Strukelj B, Menart V:
Improved determination of plasmid copy number using quantitative
real-time PCR for monitoring fermentation processes. Microb Cell Fact
2008, 7:6.
32. Carapuca E, Azzoni AR, Prazeres DM, Monteiro GA, Mergulhao FJ: Time-
course determination of plasmid content in eukaryotic and prokaryotic
cells using real-time PCR. Mol Biotechnol 2007, 37(2):120-6.
33. Lee CL, Ow DS, Oh SK: Quantitative real-time polymerase chain reaction
for determination of plasmid copy number in bacteria. J Microbiol
Methods 2006, 65(2):258-67.
34. Lee C, Kim J, Shin SG, Hwang S: Absolute and relative QPCR
quantification of plasmid copy number in Escherichia coli. J Biotechnol
2006, 123(3):273-80.
35. Tao L, Jackson RE, Rouviere PE, Cheng Q: Isolation of chromosomal
mutations that affect carotenoid production in Escherichia coli:
mutations alter copy number of ColE1-type plasmids. FEMS Microbiol Lett
2005, 243(1):227-33.
36. Lee C, Lee S, Shin SG, Hwang S: Real-time PCR determination of rRNA
gene copy number: absolute and relative quantification assays with
Escherichia coli. Appl Microbiol Biotechnol 2008, 78(2):371-6.
37. Friehs K: Plasmid copy number and plasmid stability. Adv Biochem Eng
Biotechnol 2004, 86:47-82.
38. Antoine R, Locht C: Isolation and molecular characterization of a novel
broad-host-range plasmid from Bordetella bronchiseptica with sequence
similarities to plasmids from gram-positive organisms. Mol Microbiol 1992,
6(13):1785-99.
39. Lutz R, Bujard H: Independent and tight regulation of transcriptional
units in Escherichia coli via the LacR/O, the TetR/O and AraC/I1-I2
regulatory elements. Nucleic Acids Res 1997, 25(6):1203-10.
40. Manen D, Xia G, Caro L: A locus involved in the regulation of replication
in plasmid pSC101. Mol Microbiol 1994, 11(5):875-84.
41. Grabherr R, Bayer K: Impact of targeted vector design on Co/E1 plasmid
replication. Trends Biotechnol 2002, 20(6):257-60.
42. Glass RE: Gene function: E. coli and its heritable elements. University of
California Press; 1982.
43. Kues U, Stahl U: Replication of plasmids in gram-negative bacteria.
Microbiol Rev 1989, 53(4):491-516.
44. Redding-Johanson AM, Batth TS, Chan R, Krupa R, Szmidt HL, Adams PD,
Keasling JD, Lee TS, Mukhopadhyay A, Petzold CJ: Targeted Proteomics for
Metabolic Pathway Optimization: Application to Terpene Production.
Metab Eng 2011, 13(2):194-203.
45. Dunlop MJ, Dossani ZY, Szmidt HL, Chu HC, Lee TS, Keasling JD, Hadi MZ,
Mukhopadhyay A: Engineering microbial biofuel tolerance and export
using efflux pumps. Mol Syst Biol 2011, 7:487.
46. Leguia M, Brophy J, Densmore D, Anderson JC: Automated assembly of
standard biological parts. Methods Enzymol 2011, 498:363-97.
47. Horton RM, Cai ZL, Ho SN, Pease LR: Gene splicing by overlap extension:
tailor-made genes using the polymerase chain reaction. Biotechniques
1990, 8(5):528-35.
48. Pushnova EA, Geier M, Zhu YS: An easy and accurate agarose gel assay
for quantitation of bacterial plasmid copy numbers. Anal Biochem 2000,
284(1):70-6.
49. Mason G, Provero P, Vaira AM, Accotto GP: Estimating the number of
integrations in transformed plants by quantitative real-time PCR. BMC
Biotechnol 2002, 2:20.
doi:10.1186/1754-1611-5-12
Cite this article as: Lee et al.: BglBrick vectors and datasheets: A
synthetic biology platform for gene expression. Journal of Biological
Engineering 2011 5:12.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color figure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Lee et al. Journal of Biological Engineering 2011, 5:12
http://www.jbioleng.org/content/5/1/12
Page 14 of 14
